Literature DB >> 2147027

Structure and distribution of an Alu-type deletion mutation in Sandhoff disease.

K Neote1, B McInnes, D J Mahuran, R A Gravel.   

Abstract

Sandhoff disease is a recessively inherited lysosomal storage disease resulting from a deficiency of beta-hexosaminidase activity. The enzyme occurs in two major forms, beta-hexosaminidase A, composed of an alpha- and beta-subunit and beta-hexosaminidase B, composed of two beta-subunits. Both isozyme activities are deficient in Sandhoff disease, owing to mutations of the HEXB gene encoding the common beta-subunit. We have cloned and fully characterized a deletion at the HEXB gene from fibroblasts of a patient with the infantile form of Sandhoff disease. The deletion removes approximately 16 kb of DNA including the HEXB promoter, exons 1-5 and part of intron 5. It most likely arose from recombination between two Alu sequences, with the breakpoints occurring at the midpoint between the left and right arms in each case and regenerating an intact Alu element in the deletion sequence. The deletion allele accounts for 27% of the Sandhoff mutant alleles we analyzed. Two cell lines were shown to be homozygous for the deletion and both had the infantile form of the disease. Four additional patients were compound heterozygotes with other mutations, all of whom displayed a different clinical phenotype. Finally, the mutant allele was present in different ethnic backgrounds, suggesting that it may have been subject to genetic drift.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2147027      PMCID: PMC296899          DOI: 10.1172/JCI114871

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Assignment of the human gene for hexosaminidase B to chromosome 5.

Authors:  H J Boedecker; W J Mellman; T A Tedesco; C M Croce
Journal:  Exp Cell Res       Date:  1975-07       Impact factor: 3.905

2.  Assignment of the structural genes for the alpha subunit of hexosaminidase A, mannosephosphate isomerase, and pyruvate kinase to the region q22-qter of human chromosome 15.

Authors:  C J Chern; R Kennett; E Engel; W J Mellman; C M Croce
Journal:  Somatic Cell Genet       Date:  1977-11

3.  Deficient hexosaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs.

Authors:  K Sandhoff; U Andreae; H Jatzkewitz
Journal:  Pathol Eur       Date:  1968

4.  Absence of hexosaminidase A and B in a normal adult.

Authors:  J C Dreyfus; L Poenaru; L Svennerholm
Journal:  N Engl J Med       Date:  1975-01-09       Impact factor: 91.245

5.  AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.

Authors:  E Conzelmann; K Sandhoff
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

6.  Hypobetalipoproteinemia due to an apolipoprotein B gene exon 21 deletion derived by Alu-Alu recombination.

Authors:  L S Huang; M E Ripps; S H Korman; R J Deckelbaum; J L Breslow
Journal:  J Biol Chem       Date:  1989-07-05       Impact factor: 5.157

7.  Studies on complementation of beta hexosaminidase deficiency in human GM2 gangliosidosis.

Authors:  M C Rattazzi; J A Brown; R G Davidson; T B Shows
Journal:  Am J Hum Genet       Date:  1976-03       Impact factor: 11.025

8.  Carrier detection in Sandhoff disease.

Authors:  J A Lowden; E J Ives; D L Keene; A L Burton; M A Skomorowski; F Howard
Journal:  Am J Hum Genet       Date:  1978-01       Impact factor: 11.025

9.  Juvenile Sandhoff Disease: complementation tests with Sandhoff and Tay-Sachs disease using polyethylene glycol-induced cell fusion.

Authors:  S Wood
Journal:  Hum Genet       Date:  1978-04-24       Impact factor: 4.132

10.  A difference in the specificities of human liver N-acetyl-beta-hexosaminidases A and B detected by their activities towards glycosaminoglycan oligosaccharides.

Authors:  T M Bearpark; J L Stirling
Journal:  Biochem J       Date:  1978-09-01       Impact factor: 3.857

View more
  19 in total

1.  Deletion of the 5'-region in one or two alleles of HEXB in 15 out of 30 patients with Sandhoff disease.

Authors:  P A Bolhuis; H Bikker
Journal:  Hum Genet       Date:  1992-11       Impact factor: 4.132

2.  Molecular and functional analysis of the HEXB gene in Italian patients affected with Sandhoff disease: identification of six novel alleles.

Authors:  Stefania Zampieri; Mirella Filocamo; Emanuele Buratti; Marina Stroppiano; Kristian Vlahovicek; Natalia Rosso; Eleonora Bignulin; Stefano Regis; Franco Carnevale; Bruno Bembi; Andrea Dardis
Journal:  Neurogenetics       Date:  2008-08-29       Impact factor: 2.660

Review 3.  The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.

Authors:  Gustavo H B Maegawa; Tracy Stockley; Michael Tropak; Brenda Banwell; Susan Blaser; Fernando Kok; Roberto Giugliani; Don Mahuran; Joe T R Clarke
Journal:  Pediatrics       Date:  2006-10-02       Impact factor: 7.124

Review 4.  Chaperone therapy for GM2 gangliosidosis: effects of pyrimethamine on β-hexosaminidase activity in Sandhoff fibroblasts.

Authors:  Elena Chiricozzi; Natalia Niemir; Massimo Aureli; Alessandro Magini; Nicoletta Loberto; Alessandro Prinetti; Rosaria Bassi; Alice Polchi; Carla Emiliani; Catherine Caillaud; Sandro Sonnino
Journal:  Mol Neurobiol       Date:  2013-12-20       Impact factor: 5.590

5.  A common beta hexosaminidase gene mutation in adult Sandhoff disease patients.

Authors:  M Gomez-Lira; A Sangalli; M Mottes; C Perusi; P F Pignatti; N Rizzuto; A Salviati
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

6.  Mutation analysis of a Sandhoff disease patient in the Maronite community in Cyprus.

Authors:  Y Hara; P Ioannou; A Drousiotou; G Stylianidou; V Anastasiadou; K Suzuki
Journal:  Hum Genet       Date:  1994-08       Impact factor: 4.132

7.  Homozygous hereditary C3 deficiency due to a partial gene deletion.

Authors:  M Botto; K Y Fong; A K So; R Barlow; R Routier; B J Morley; M J Walport
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

8.  An unusual splicing mutation in the HEXB gene is associated with dramatically different phenotypes in patients from different racial backgrounds.

Authors:  B McInnes; M Potier; N Wakamatsu; S B Melancon; M H Klavins; S Tsuji; D J Mahuran
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

9.  Homologous recombination among three intragene Alu sequences causes an inversion-deletion resulting in the hereditary bleeding disorder Glanzmann thrombasthenia.

Authors:  L Li; P F Bray
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

10.  Sandhoff disease in Argentina: high frequency of a splice site mutation in the HEXB gene and correlation between enzyme and DNA-based tests for heterozygote detection.

Authors:  F E Kleiman; R D de Kremer; A O de Ramirez; R A Gravel; C E Argaraña
Journal:  Hum Genet       Date:  1994-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.